Delivery Order SPE2DR25D2106-SPE2DR26F1FNE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,079.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100-count) with a ceiling value of $5,176.58 under a firm fixed-price contract type. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and no set-aside designation was utilized. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) with a ceiling value of $8,109.38. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 24, 2025, for 100 capsules of Lisdexamfetamine 30 mg with a ceiling value of $1,070.16. This is a firm fixed price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $2,762.83. This is a firm fixed-price, non-set-aside delivery order that must be completed by May 14, 2025, with performance executed from the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count) with a contract value of $1,625.77 and an ultimate completion date of October 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count units) with a ceiling value of $1,278.13. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,672.67 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units). This is a firm fixed-price contract with an ultimate completion date of October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100-count unit) on June 3, 2025, with a ceiling value of $1,454.76 and completion deadline of June 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) valued at $4,178.96. This delivery order, which carries a firm fixed price and is scheduled for completion by October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was not designated as a set-aside contract and was...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1FNEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count unit) with a ceiling value of $1,216.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of November 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts predominantly with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Lisdexamfetamine—a controlled-release stimulant medication commonly used in attention-deficit treatment—reflects the company's role as a critical vendor for federal military and veteran healthcare procurement. No set-aside designation was applied to this award, indicating it was awarded through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/3/25 |